Two Sigma Advisers’s Asensus Surgical, Inc. ASXC Stock Holding History

Two Sigma Advisers’s Portfolio ASXC Stock Details ASXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-11,900	Closed	-$2.74K	–	2730
2024 Q1	$2.74K	Buy	+11,900	New	+$3.46K	﹤0.01%	2429
2023 Q4	–	Sell	-12,400	Closed	-$3.35K	–	2678
2023 Q3	$3.35K	Sell	12,400 -100	-0.8%	-$36	﹤0.01%	2362
2023 Q2	$6.31K	Sell	12,500 -400	-3%	-$239	﹤0.01%	2351
2023 Q1	$8.49K	Buy	+12,900	New	+$8.74K	﹤0.01%	2550
2020 Q3	–	Sell	-93,667	Closed	-$51K	–	2673
2020 Q2	$51K	Buy	93,667 +25,400	+37%	+$12.3K	﹤0.01%	2422
2020 Q1	$24K	Buy	68,267 +57,624	+541%	+$60.2K	﹤0.01%	2408
2019 Q4	$16K	Buy	+10,643	New	+$37K	﹤0.01%	2331
2019 Q3	–	Sell	-3,238	Closed	-$57K	–	2431
2019 Q2	$57K	Sell	3,238 -6,485	-67%	-$142K	﹤0.01%	2245
2019 Q1	$301K	Sell	9,723 -146	-1%	-$4.89K	﹤0.01%	1988
2018 Q4	$290K	Sell	9,869 -2,292	-19%	-$104K	﹤0.01%	2000
2018 Q3	$917K	Buy	+12,161	New	+$823K	﹤0.01%	1534

Other funds holding ASXC

BCM

Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Crystalline Management Montreal, Quebec, Canada $112M AUM 21.13% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Two Sigma Advisers's ASXC Position: Q2 2024 in Review

Two Sigma Advisers sold out of Asensus Surgical, Inc. (ASXC) in Q2 2024, closing a stake of 11,900 shares — an estimated $2.74K sold.

Two Sigma Advisers first reported a position in ASXC in Q3 2018 and held it in 11 quarters. The position peaked at $917K in Q3 2018. 64 funds tracked by Wall St. Rank hold ASXC as of Q2 2024.

Two Sigma Advisers reported no remaining Asensus Surgical, Inc. position as of Q2 2024 after selling out during the quarter.
Two Sigma Advisers sold 11,900 Asensus Surgical, Inc. shares in Q2 2024, an estimated $2.74K.
Two Sigma Advisers first reported a position in Asensus Surgical, Inc. in Q3 2018 and held it in 11 quarters.
Two Sigma Advisers's Asensus Surgical, Inc. position peaked at $917K in Q3 2018.
64 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q2 2024.

Based on Two Sigma Advisers's 13F filing for Q2 2024, filed 14 Aug 2024.